Physician profile
Haley E Boyd
NPI 1821706763
$713.45
in general payments reported to CMS, 2019-2025
14 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.94 · 2023: $34.40 · 2024: $520 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.51 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $207.45 | 2024-2025 | Intracept Rf Probe, Watchman Flx |
| Stryker Corporation | $97.71 | 2024-2025 | Augment Injectable, Universal Neuro 3, Duramatrix |
| Astrazeneca Pharmaceuticals Lp | $96.47 | 2023-2024 | Andexxa |
| Ucb, INC. | $72.35 | 2022-2024 | Briviact |
| Integra Lifesciences Corporation | $46.23 | 2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Ethicon US, LLC | $35.83 | 2024 | Stratafix, Surgicel Nu-Knit |
| Abbvie INC. | $33.06 | 2025 | |
| Lilly USA, LLC | $22.52 | 2025 | Emgality, Reyvow |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Merz Pharmaceuticals, LLC | $17.63 | 2024 | Xeomin |
| Kerecis Limited | $17.55 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Zimmer Biomet Holdings, INC. | $16.69 | 2024 | Neuro Plating System |
| Medtronic, INC. | $15.53 | 2025 | |
| Si-Bone, INC. | $14.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.